Big U.S. pharmacies square off on Daraprim supplies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Leerink Partners Remains Bullish Following Express Scripts (ESRX) 2016 Guidance Release
December 22, 2015 9:19 AM ESTLeerink Partners reiterated an Outperform rating on Express Scripts (NASDAQ: ESRX) after the company issued its 2016 guidance this morning. The guidance calls for adjusted EPS of $6.08 to $6.28 (vs. consensus of $6.05). Total 2016 adjusted claims guidance of 1,255M-1,295M is inline with the preliminary claims... More
